In Brief
This article was originally published in The Tan Sheet
Executive Summary
CHPA stands up for gluten in OTCs; Sen. Durbin targets energy drink supplement labeling; CDC report delves into U.S. nutritional data; P&G files tooth whitening patent suit against Be Well Health Marketing; more news In Brief.
You may also be interested in...
Gluten-Drug Rule Petitioner Claims Time Has Expired For FDA Decision
A lawsuit seeks to declare FDA’s failure to act on a 2008 citizen petition requesting a ban of wheat gluten in OTCs and Rx drugs in violation of the Administrative Procedure Act. The complaint alleges the agency’s delay is unreasonable and asks the court to order FDA to make a decision within 30 days.
Gluten-Drug Rule Petitioner Claims Time Has Expired For FDA Decision
A lawsuit seeks to declare FDA’s failure to act on a 2008 citizen petition requesting a ban of wheat gluten in OTCs and Rx drugs in violation of the Administrative Procedure Act. The complaint alleges the agency’s delay is unreasonable and asks the court to order FDA to make a decision within 30 days.
In Brief
FDA issued warning letters Sept. 21 to two skin-care companies it says are making unapproved drug claims. More news in brief.